arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

DocGo Inc.

DCGO
$0.64 ▲ +0.02 (+3.47%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
23 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

DocGo Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $63.2M
Dividend Yield
Revenue Growth -21.3%
Op. Margin -24.8%
ROIC -14.1%
FCF / Share $-0.05
Trailing P/E
Price / Book 0.5x
FCF Yield
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Aug 7, 2026.

23-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$75.55M
↓ -21.3%
Net Income Profit after all expenses
$-14.76M
↓ -33.2%
Operating Margin Operating profit as % of sales
-24.8%
↑ +82.3% 5th
FCF / Share Free cash flow per share
$-0.05
↓ -744.0%
Long-Term Debt Long-term obligations
$220.99K
↓ -6.2%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
23
Returns
6
Financial Health
54
Cash Quality
17

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 23 quarters